
Hilma Biocare
Semaglutide
GLP-1 receptor agonist. The active compound in Ozempic/Wegovy research.
99.0%· Janoshik
GLP-1 agonists and metabolic compounds. Semaglutide, Retatrutide, Clenbuterol, T3/T4.

Hilma Biocare
GLP-1 receptor agonist. The active compound in Ozempic/Wegovy research.
99.0%· Janoshik

Hilma Biocare
Pre-filled semaglutide pen. Convenient auto-injector for research use.
99.0%· Janoshik

Pharmacom Labs
Pharmacom T3 liothyronine. 50mcg double-strength tablets.
99%+· Pharmacom

Pharmacom Labs
Sibutramine 15mg double-strength tablets. Central appetite research.
99%+· Pharmacom

ZPHC
Semaglutide 5mg kit (5×1mg) by ZPHC. GLP-1 receptor agonist.
99%+· ZPHC

ZPHC
Semaglutide 10mg kit (5×2mg) by ZPHC. Best-value GLP-1 research kit.
99%+· ZPHC

ZPHC
Semaglutide 6mg premixed AQ pen by ZPHC. Ready-to-inject.
99%+· ZPHC

ZPHC
Tirze 15mg single vial by ZPHC. Dual GIP/GLP-1 agonist.
99%+· ZPHC

ZPHC
Tirze 25mg kit (5×5mg) by ZPHC. Dual GIP/GLP-1 agonist.
99%+· ZPHC

ZPHC
Tirze 30mg premixed AQ pen by ZPHC. Ready-to-inject dual agonist.
99%+· ZPHC

ZPHC
Tirze 75mg dual-chamber auto-mixing pen by ZPHC. Long-term supply.
99%+· ZPHC

ZPHC
Clen 40mcg tablets by ZPHC. Beta-2 adrenergic agonist.
99%+· ZPHC

ZPHC
Cagrilintide 25mg by ZPHC. Long-acting amylin analogue for weight research.
99%+· ZPHC
Resellers, laboratories and publishers: apply for partner pricing, volume terms and a dedicated representative.
Research use only. All products are sold strictly for in-vitro and laboratory research. Not for human consumption, veterinary use, diagnosis, treatment or prevention of any disease. Products sold by JuicedPharma are not medicines. By ordering you confirm you are a qualified person buying for research in compliance with applicable regulations. Full disclaimer